BULLISHWHALES
BullishWhales · Analysts · Analyst Profile
BW Score Rank#179 of 347

Patrick R. Trucchio

HC Wainwright & Co. · Equity Research Analyst
EstablishedRating since 2021No new ratings since Jun 2025

Analyst rating accuracy & track record

Patrick R. Trucchio is an equity research analyst at HC Wainwright & Co.. Bullish Whales has scored 154 of their stock calls across 16 companies. Their picks beat their sector 35% of the time over the next 12 months, and their price targets were reached 8% of the time within a year.

Win % vs sector
35%
PT Hit % (12mo)
8%
Avg sector-excess
−7.4%
Scored calls
154
Tickers
16
Tier
Established

Track record

Bullish Whales has scored 154 of Patrick R. Trucchio's stock calls across 16 companies, dating back to 2021. Their rated stocks beat their own sector 35% of the time over the next 12 months. On a typical call, a Trucchio pick returned −7.4% more than its sector over the following year.

Of the scored calls, 154 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.

Coverage & ratings

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
IMCRImmunocore Holdings Ltd
Buy$100.00Jun 2025−35.5%Miss
ONCYOncolytics Biotech Inc
Buy$5.00May 2025+81.1%Miss
DTILPrecision BioSciences Inc
Buy$60.00May 2025+38.6%Miss
ARWRArrowhead Pharmaceuticals Inc
Buy$80.00May 2025+390.0%Hit
ATAIATAI Life Sciences BV
Buy$10.00May 2025+100.3%Miss
CMPSCompass Pathways Plc
Buy$45.00May 2025+127.7%Miss
VYGRVoyager Therapeutics Inc
Buy$30.00Apr 2025+16.3%Miss
HRMYHarmony Biosciences Holdings
Buy$70.00Apr 2025−11.9%Miss
SGMOSangamo Therapeutics Inc
Buy$10.00Apr 2025−70.8%Miss
BEAMBeam Therapeutics Inc
Buy$80.00Apr 2025+56.2%Miss
ALTAltimmune Inc
Buy$12.00Apr 2025−31.5%Miss
MISTMilestone Pharmaceuticals Inc
Buy$10.00Apr 2025+58.9%Miss
MISTMilestone Pharmaceuticals Inc
Buy$25.00Mar 2025+26.0%Miss
DTILPrecision BioSciences Inc
Buy$60.00Mar 2025+13.4%Miss
DTILPrecision BioSciences Inc
Buy$60.00Mar 2025+23.9%Miss
ATAIATAI Life Sciences BV
Buy$10.00Mar 2025+159.1%Miss
GOSSGossamer Bio Inc
Buy$10.00Mar 2025−70.0%Miss
ALTAltimmune Inc
Buy$12.00Mar 2025−43.0%Miss
MISTMilestone Pharmaceuticals Inc
Buy$25.00Mar 2025−28.9%Miss
VYGRVoyager Therapeutics Inc
Buy$30.00Mar 2025+9.2%Miss
IMCRImmunocore Holdings Ltd
Buy$100.00Mar 2025+3.6%Miss
ONCYOncolytics Biotech Inc
Buy$5.00Mar 2025+59.8%Miss
BEAMBeam Therapeutics Inc
Buy$80.00Mar 2025−8.0%Miss
SLNSilence Therapeutics PLC
Buy$75.00Mar 2025+31.3%Miss
IMCRImmunocore Holdings Ltd
Buy$100.00Mar 2025−1.3%Miss
CMPSCompass Pathways Plc
Buy$45.00Mar 2025+67.7%Miss
ALTAltimmune Inc
Buy$12.00Mar 2025−37.8%Miss
VYGRVoyager Therapeutics Inc
Buy$30.00Mar 2025−4.9%Miss
MISTMilestone Pharmaceuticals Inc
Buy$25.00Feb 2025−3.0%Miss
VIRVir Biotechnology Inc
Buy$110.00Feb 2025+10.1%Miss
BEAMBeam Therapeutics Inc
Buy$80.00Feb 2025+6.5%Miss
IMCRImmunocore Holdings Ltd
Buy$100.00Feb 2025+5.3%Miss
HRMYHarmony Biosciences Holdings
Buy$70.00Feb 2025−25.1%Miss
DTILPrecision BioSciences Inc
Buy$60.00Feb 2025−42.1%Miss
CMPSCompass Pathways Plc
Buy$45.00Feb 2025+16.3%Miss
ATAIATAI Life Sciences BV
Buy$10.00Feb 2025+44.4%Miss
ALTAltimmune Inc
Buy$12.00Feb 2025−35.9%Miss
ONCYOncolytics Biotech Inc
Buy$5.00Feb 2025+15.8%Miss
SLNSilence Therapeutics PLC
Buy$75.00Feb 2025−20.4%Miss
BEAMBeam Therapeutics Inc
Buy$80.00Feb 2025+1.7%Miss
VIRVir Biotechnology Inc
Buy$110.00Jan 2025−30.2%Miss
GOSSGossamer Bio Inc
Buy$10.00Jan 2025+122.2%Miss
ATAIATAI Life Sciences BV
Buy$10.00Jan 2025+133.8%Miss
SLNSilence Therapeutics PLC
Buy$75.00Jan 2025−11.8%Miss
ATAIATAI Life Sciences BV
Buy$10.00Jan 2025+150.2%Miss
VYGRVoyager Therapeutics Inc
Buy$30.00Jan 2025−37.6%Miss
MISTMilestone Pharmaceuticals Inc
Buy$25.00Jan 2025−6.4%Miss
SGMOSangamo Therapeutics Inc
Buy$10.00Jan 2025−74.4%Miss
IMCRImmunocore Holdings Ltd
Buy$100.00Jan 2025+1.3%Miss
ALTAltimmune Inc
Buy$12.00Jan 2025−32.2%Miss
Go to

Patrick R. Trucchio: analyst track record FAQ

Is Patrick R. Trucchio a good stock analyst?

Yes, by track record. Patrick R. Trucchio ranks number 179 of 347 of the analysts Bullish Whales scores, with a BW Score of 28 out of 100. Past results do not guarantee future ones.

What is Patrick R. Trucchio's win rate?

Patrick R. Trucchio's win rate is 35%. Across 154 scored calls, their rated stocks beat their sector 35% of the time over the next 12 months. On a typical call they returned −7.4% more than the sector.

What stocks and sectors does Patrick R. Trucchio cover?

Patrick R. Trucchio covers 16 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.

Are Patrick R. Trucchio's price targets accurate?

Patrick R. Trucchio's price targets are reached within 12 months 8% of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.

How accurate are Wall Street analyst price targets?

Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.

Should I follow Patrick R. Trucchio's stock ratings?

Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.

How does Bullish Whales score analyst accuracy?

Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.

How does Patrick R. Trucchio rank among Wall Street analysts?

Patrick R. Trucchio ranks number 179 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30